XML 49 R40.htm IDEA: XBRL DOCUMENT v3.23.1
LIQUIDITY AND GOING CONCERN (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
May 26, 2022
Feb. 28, 2023
Dec. 31, 2022
Dec. 31, 2021
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Restructuring Cost and Reserve [Line Items]              
Cash     $ 7,034,434   $ 4,362,757   $ 7,034,434
Accumulated deficit     103,385,172   107,231,393   $ 103,385,172
Net cash used in operating activities         $ 2,634,093 $ 3,881,611  
Proceeds from issuance of common stock       $ 8,800,000      
Proceeds from issuance of debt     $ 3,000,000.0        
Stockholders equity note stock split             the Company with a face value equal to the amount paid by the Company to NanoSynex upon satisfaction of the applicable performance milestone, bearing interest at the rate of 9% per annum on the principal balance from time to time outstanding under the particular promissory note, convertible at the option of the Company into additional shares of NanoSynex in order for the Company to maintain at least a 50.1% controlling ownership interest in NanoSynex, should NanoSynex issue additional shares. The principal of the convertible notes are due and payable upon the sooner to occur of: i) five years from the date of issuance of the particular promissory note; ii) the acquisition by any person or entity of all or substantially all of the share capital of NanoSynex, through share purchase, issuance or shares or merger of NanoSynex, or the purchase of all or substantially all of the assets of NanoSynex; or iii) the initial public offering of NanoSynex
Nano Synex Ltd [Member]              
Restructuring Cost and Reserve [Line Items]              
Stock issued during period value acquisitions $ 1,904,989           $ 10,400,000
Stock issued during period value new issues   $ 500,000         $ 2,400,000